-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
NRX Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
- NRX Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$3.02M, a 48% increase year-over-year.
- NRX Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$20.5M, a 38.5% increase year-over-year.
- NRX Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$27.8M, a 37.2% increase from 2022.
- NRX Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$44.3M, a 61.7% increase from 2021.
- NRX Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$116M, a 125% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)